Search results
EXCLUSIVE: Woman is turned away by multiple doctors before they realize she has cancer
The Today Show via AOL· 2 days ago“He wanted me to get some testing.” That surgeon sent her for an X-ray and then an MRI and by...
Marquette president Michael Lovell dies from cancer in Rome
New York Daily News· 6 days agoLovell, who was diagnosed with sarcoma three years ago, was with his wife on a Jesuit formation...
Marquette University President Michael Lovell dies in Rome
San Francisco Chronicle· 6 days agoMarquette University President Michael Lovell has died in Rome after a three-year battle with cancer...
Another Approach To Checkpoint Inhibitors: Targeting Receptors
Forbes· 6 days agoAn alternative to PD-1 targeting cancer therapies, PD-L1 checkpoint inhibitors boost antitumor...
Molecular Characterization Initiative for Childhood Cancers
National Cancer Institute· 2 days agoWhat is molecular characterization? Looking at cancer at a molecular level helps to provide a...
Knight Therapeutics Inc. (TSE:GUD) Senior Officer Amal Khouri Sells 20,000 Shares
ETF DAILY NEWS· 1 day agoKnight Therapeutics Inc. (TSE:GUD – Get Free Report) Senior Officer Amal Khouri sold 20,000 shares of the company’s stock in a transaction on Monday, June 10th. The shares were sold at an average ...
StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
ETF DAILY NEWS· 3 days agoInvestment analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “sell” rating ...
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 3 days agoTRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. Separately ...
Iowa, Illinois, Wisconsin news in brief
telegraphherald.com· 5 days agoFour Iowa college instructors teaching in China were attacked while visiting a public park, Cornell College confirmed Monday. Cornell College President Jonathan Brand in a statement said the ...
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with...
KSAN - KLST San Angelo· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...